Vantage Investment Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $12K | Hold |
240
| – | – | ﹤0.01% | 510 |
|
|
2018
Q2 | $8K | Hold |
240
| – | – | ﹤0.01% | 581 |
|
|
2018
Q1 | $7K | Hold |
240
| – | – | ﹤0.01% | 617 |
|
|
2017
Q4 | $11K | Hold |
240
| – | – | ﹤0.01% | 565 |
|
|
2017
Q3 | $9K | Hold |
240
| – | – | ﹤0.01% | 585 |
|
|
2017
Q2 | $11K | Hold |
240
| – | – | ﹤0.01% | 532 |
|
|
2017
Q1 | $11K | Buy |
+240
| New | +$11K | ﹤0.01% | 515 |
|
|
2016
Q3 | – | Sell |
-250
| Closed | -$8K | – | 824 |
|
|
2016
Q2 | $8K | Hold |
250
| – | – | ﹤0.01% | 560 |
|
|
2016
Q1 | $13K | Hold |
250
| – | – | 0.01% | 479 |
|
|
2015
Q4 | $19K | Hold |
250
| – | – | 0.01% | 395 |
|
|
2015
Q3 | $10K | Hold |
250
| – | – | 0.01% | 495 |
|
|
2015
Q2 | $18K | Hold |
250
| – | – | 0.01% | 395 |
|
|
2015
Q1 | $22K | Hold |
250
| – | – | 0.01% | 480 |
|
|
2014
Q4 | $22K | Hold |
250
| – | – | 0.01% | 358 |
|
|
2014
Q3 | $24K | Hold |
250
| – | – | 0.01% | 327 |
|
|
2014
Q2 | $23K | Hold |
250
| – | – | 0.01% | 348 |
|
|
2014
Q1 | $17K | Hold |
250
| – | – | 0.01% | 368 |
|
|
2013
Q4 | $14K | Buy |
+250
| New | +$14K | 0.01% | 363 |
|